National Institute of Allergy and Infectious Diseases, USA
view profile
Dr. Guo-Yun Chen
University of Tennessee Health Science Center, USA
view profile
Elena Chaves Pozo
Instituto Español de Oceanografía (IEO), CSIC, Spain
view profile
Dr. Ping Xie
Rutgers University, USA
view profile
Dr. Manisha Singh
MDACC, USA
view profile
Dr. Xiufen Zheng
Western University, London, Canada
view profile
Dr.Deok Ryun Kim
International Vaccine Institute, South Korea
view profile
Balazs Sarkadi
RCNS Hungary - CelluVir Kft, Hungary
view profile
Dr. Sheng ZENG
Nanfang college, Guanghzou, China
view profile
Dr. Zhujun Ao
University of Manitoba, Canada
view profile
Dr. Massimiliano Bissa
NCI/NIH, USA
view profile
Dr. Charles Jones
Pfizer, USA
view profile
Dr. Maya Leticia
CENUR Litoral Norte - Centro universitario Salto, uruguay
view profile
Dr. Robert N.J. Conradt
conradt measurement and control technique, Germany
view profile
Dr. Evan Levy
Albert Einstein College of Medicine, USA
view profile
Patricia Morán
Faculty Of Medicine, National Autonomous University of Mexico, Mexico
view profile
Liliana Rojas-Velàzquez
National Autonomous University of Mexico, Mexico
view profile
Dr. Rhea N. Coler
University of Washington School of Medicine, USA
view profile
Dr. Horacio Bach
University of British Columbia, Canada
view profile
Dr. Manisha Pandey
Griffith University, Australia
view profile
Dr. Hira L Nakhasi
U.S. Food and Drug Administration , USA
view profile
Dr. Dilruba Nasrin
University of Maryland, Baltimore, USA
view profile
Dr. Wei Wang
Brigham and Women’s Hospital/Harvard Medical School, USA
view profile
Dr. Xingmin Sun
University of South Florida, USA
Dr. Nisha Jain Garg University of Texas Medical Branch, USA
Vaccine Research and Development
Title of speech: Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice
Dr. Liang Zhou University of Florida, Gainesville, Florida, USA
Immunopathology
Title of speech : The role of Innate Lymphoid Cells in Mucosal Infection
Dr. Tian Wang University of Texas Medical Branch, USA
Development of safe and efficacious vaccines against emerging arboviruses
Title of speech : Development of safe and efficacious vaccines against emerging arboviruses
Dr. Mari Numata-Nakamura Harvard Medical School, USA
Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine
Title of speech : Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine
Dr.Donald A. Berry University of Texas, USA
Bayesian Analyses for Adaptive Clinical Trial Designs: Application to Lecanemab Phase 2b Dose-finding Trial in Alzheimer Disease
Title of speech : Bayesian Analyses for Adaptive Clinical Trial Designs:
Application to Lecanemab Phase 2b Dose-finding Trial in Alzheimer Disease
Dr Geeta Hitch University of Sunderland In London, UK
BARRIERS TO CHILDHOOD IMMUNIZATION UPTAKE IN THE COUNTRIES IN WEST AFRICA: A SYSTEMATIC LITERATURE REVIEW
Title of speech : BARRIERS TO CHILDHOOD IMMUNIZATION UPTAKE IN THE COUNTRIES IN WEST AFRICA: A SYSTEMATIC LITERATURE REVIEW
Dr. Lauren Eyler Dang National Institute of Allergy and Infectious Diseases, USA
Causal frameworks for designing studies of immune correlates of risk for vaccine-preventable diseases: Start with the Target Trial Protocol, then follow the Roadmap for Causal Inference
Title of speech : Causal frameworks for designing studies of immune correlates of risk for vaccine-preventable diseases:
Start with the Target Trial Protocol, then follow the Roadmap for Causal Inference
Dr. Guo-Yun Chen University of Tennessee Health Science Center, USA
Targeting Intracellular Neu1 for Coronavirus Infection Treatment
Title of speech : Targeting Intracellular Neu1 for Coronavirus Infection Treatment
Elena Chaves Pozo Instituto Español de Oceanografía (IEO), CSIC, Spain
Inheritance of maternally trained immunity in teleost fish
Title of speech: Inheritance of maternally trained immunity in teleost fish
Dr. Ping Xie Rutgers University, USA
The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion
Title of speech: The adaptor protein TRAF3 is an immune checkpoint that inhibits
myeloid-derived suppressor cell expansion
Dr. Manisha Singh MDACC, USA
Enhancing Immunotherapy Efficacy and Reducing Toxicity in Pancreatic Cancer through IL-1 Pathway Blockade
Title of speech: Enhancing Immunotherapy Efficacy and Reducing Toxicity in Pancreatic Cancer through IL-1 Pathway Blockade
Dr. Xiufen Zheng Western University, London, Canada
The role of circular RNA in dendritic cells: a new target for robust dendritic cell vaccine
Title of speech: The role of circular RNA in dendritic cells: a new target for robust dendritic cell vaccine
Dr.Deok Ryun Kim International Vaccine Institute, South Korea
Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
Title of speech: Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
A new method for assessing antiviral cellular immunity by a microneedle skin patch
Title of speech: A new method for assessing antiviral cellular immunity
by a microneedle skin patch
Dr. Sheng ZENG Nanfang college, Guanghzou, China
Telacebec Interferes with Virulence Lipid Biosynthesis Protein Expression and Sensitizes to Other Antibiotics
Title of speech: Telacebec Interferes with Virulence Lipid Biosynthesis Protein Expression and Sensitizes to Other Antibiotics
Dr. Zhujun Ao University of Manitoba, Canada
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
Title of speech: Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
Dr. Massimiliano Bissa NCI/NIH, USA
Evaluation of the effect of ALFQA adjuvant on immunogenicity and efficacy of the V1-deleted DNA/ALVAC/gp120 anti-HIV vaccine candidate
Title of speech: Evaluation of the effect of ALFQA adjuvant on immunogenicity and efficacy of the V1-deleted DNA/ALVAC/gp120 anti-HIV vaccine candidate
Dr. Charles Jones Pfizer, USA
Navigating the future adult vaccine landscape - innovation, an aging population and crowded schedules
Title of speech: Navigating the future adult vaccine landscape - innovation, an aging population and crowded schedules
Dr. Maya Leticia CENUR Litoral Norte - Centro universitario Salto, uruguay
Coding-complete genome sequences of two Bovine viral diarrhea virus 1a isolates
Title of speech: Coding-complete genome sequences of two Bovine viral diarrhea virus 1a isolates
Dr. Robert N.J. Conradt conradt measurement and control technique, Germany
The dynamic reproduction index: precise determination from the incidence and insights based on new state diagrams
Title of speech: The dynamic reproduction index: precise determination from the incidence and insights based on new state diagrams
Dr. Evan Levy Albert Einstein College of Medicine, USA
Tumor-targeted delivery of Tetanus toxoid by Listeria converts ovarian tumors from cold to hot
Title of speech: Tumor-targeted delivery of Tetanus toxoid by Listeria converts ovarian tumors from cold to hot
Patricia Morán Faculty Of Medicine, National Autonomous University of Mexico, Mexico
Seroconversion induced by vaccination against COVID-19 in Mexico City, Mexico
Title of speech: Seroconversion induced by vaccination against COVID-19 in Mexico City, Mexico
Liliana Rojas-Velàzquez National Autonomous University of Mexico, Mexico
Symptoms caused by the SARS-Cov-2 virus in outpatients: an overview of different waves
Title of speech: Symptoms caused by the SARS-Cov-2 virus in outpatients: an overview of different waves
Dr. Rhea N. Coler University of Washington School of Medicine, USA
An RNA-based vaccine for tuberculosis
Title of speech: An RNA-based vaccine for tuberculosis
Dr. Horacio Bach University of British Columbia, Canada
Neutralization of SARS-CoV-2 by single-chain antibodies – a way to vaccine development
Title of speech: Neutralization of SARS-CoV-2 by single-chain antibodies – a way to vaccine development
Dr. Manisha Pandey Griffith University, Australia
A Synthetic Peptide Vaccine Demonstrates Prophylactic and Therapeutic Efficacy Against Streptococcal Superficial and Invasive Infections
Title of speech: A Synthetic Peptide Vaccine Demonstrates Prophylactic and Therapeutic Efficacy Against Streptococcal Superficial and Invasive Infections
Dr. Hira L Nakhasi U.S. Food and Drug Administration , USA
Advancement in Leishmania vaccination development and its role in global elimination of leishmaniasis
Title of speech: Advancement in Leishmania vaccination development and its role in global elimination of leishmaniasis
Dr. Dilruba Nasrin University of Maryland, Baltimore, USA
Enteropathogens associated with linear growth faltering in children in Africa and impact of antibiotic treatment
Title of speech: Enteropathogens associated with linear growth faltering in children in Africa and impact of antibiotic treatment
Dr. Wei Wang Brigham and Women’s Hospital/Harvard Medical School, USA
Identify patterns and risk factors of post-COVID-19 vaccination side effects
Title of speech: Identify patterns and risk factors of post-COVID-19 vaccination side effects
Dr. Xingmin Sun University of South Florida, USA
Recombinant fusion protein vaccine containing Clostridioides difficile FliC and FliD protects mice against C. difficile infection
Title of speech Recombinant fusion protein vaccine containing Clostridioides difficile FliC and FliD protects mice against C. difficile infection